Clinical and pharmacological group: & nbsp

Means for enteral and parenteral nutrition

Included in the formulation
АТХ:

B.05.B.A.04   Protein hydrolysates

Pharmacodynamics:

Amino acid preparation containing all essential and non-essential amino acids. Obtained by deep hydrolysis of human blood proteins with correction of the composition by the addition of synthetic amino acids and the energy component of D-sorbitol.

Pharmacokinetics:

No data.

Indications:

Violation of protein assimilation, preparation for operative intervention and postoperative period, protein deficiency (burn disease, injuries, bone fractures, acute infections, decreased appetite of various origin, flaccid wounds, nonspecific inflammatory processes in the lungs, reconvalescence).

IV.E40-E46.E46   Protein-energy insufficiency, unspecified

Contraindications:

Hypersensitivity, acute and subacute liver and / or renal failure, cerebral circulatory disorders, cardiovascular and cardiopulmonary insufficiency.

Carefully:

Renal and hepatic insufficiency.

Pregnancy and lactation:

No data.

Dosing and Administration:

Intravenously, drip (in hospital), 90-150 ml / h at a speed of 30-50 drops per minute; daily dose of 10-25 ml / kg, for children - 25-50 ml / kg.

Side effects:

If the rate of administration is exceeded, allergic reactions are possible.

Overdose:

No data.

Interaction:

Pharmaceutically compatible with glucose solutions, fat emulsions and saline solutions.

Special instructions:

There are no special instructions.

Instructions
Up